55 results
Page 2 of 3
8-K
EX-10.1
ghwe p3w3fojvszyz2qo
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
424B5
f2al83y9n9 u9bq8cq4r
2 Jun 20
Prospectus supplement for primary offering
5:05pm
8-K
EX-1.1
1fpnk
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
424B5
u4xd 4x3l
1 Jun 20
Prospectus supplement for primary offering
6:06am
8-K
EX-10.1
79808ld84rlq a28p
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
424B5
qh1ych av95d7je
22 Jan 20
Prospectus supplement for primary offering
5:31pm
8-K
EX-1.1
sdt34o8s
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm
424B5
a5m4vx
21 Jan 20
Prospectus supplement for primary offering
5:21pm
8-K
EX-10.1
3zcqyy5
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
sxp64uo20 cvid89d70
1 Oct 19
Adaptimmune Announces Appointment of Michael Garone as Interim Chief Financial Officer
8:14am
8-K
EX-10.1
oy3x1i98e 5l7sgi
1 Aug 19
New Executive Team Announced at Adaptimmune
7:22am
8-K
EX-10.4
ixmknimdm4
27 Jun 19
Departure of Directors or Certain Officers
8:08am
8-K
EX-10.1
ds25alaofnpnwyc0oo8f
27 Jun 19
Departure of Directors or Certain Officers
8:08am